Cargando…
Enabling Large‐Scale Ex Vivo Production of Megakaryocytes from CD34(+) Cells Using Gas‐Permeable Surfaces
Patients suffering from acute or sustained thrombocytopenia require platelet transfusions, which are entirely donor‐based and limited by challenges related to storage and fluctuating supply. Developing cell‐culture technologies will enable ex vivo and donor‐independent platelet production. However,...
Autores principales: | Martinez, Andres F., Miller, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591548/ https://www.ncbi.nlm.nih.gov/pubmed/30848565 http://dx.doi.org/10.1002/sctm.18-0160 |
Ejemplares similares
-
Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing
por: Tanaka, Rica, et al.
Publicado: (2021) -
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
por: O'Rourke, Brian, et al.
Publicado: (2021) -
CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes
por: Ostrominski, John W., et al.
Publicado: (2020) -
The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests
por: Inagaki, Emi, et al.
Publicado: (2022) -
Viral pandemic preparedness: A pluripotent stem cell‐based machine‐learning platform for simulating SARS‐CoV‐2 infection to enable drug discovery and repurposing
por: Esmail, Sally, et al.
Publicado: (2020)